Vontobel Holding’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.1M | Buy |
719,676
+37,455
| +5% | +$628K | 0.04% | 217 |
|
|
2025
Q1 | $10.5M | Sell |
682,221
-5,040
| -0.7% | -$77.5K | 0.04% | 225 |
|
|
2024
Q4 | $15.1M | Buy |
687,261
+58,772
| +9% | +$1.3M | 0.05% | 184 |
|
|
2024
Q3 | $11.3M | Sell |
628,489
-332,717
| -35% | -$6M | 0.04% | 212 |
|
|
2024
Q2 | $15.6M | Sell |
961,206
-126,361
| -12% | -$2.05M | 0.05% | 178 |
|
|
2024
Q1 | $15.3M | Sell |
1,087,567
-224,567
| -17% | -$3.17M | 0.12% | 163 |
|
|
2023
Q4 | $13.7M | Sell |
1,312,134
-22,084
| -2% | -$231K | 0.11% | 171 |
|
|
2023
Q3 | $13.6M | Sell |
1,334,218
-57,602
| -4% | -$588K | 0.13% | 168 |
|
|
2023
Q2 | $10.5M | Sell |
1,391,820
-149,186
| -10% | -$1.12M | 0.09% | 202 |
|
|
2023
Q1 | $13.6M | Sell |
1,541,006
-94,379
| -6% | -$835K | 0.13% | 168 |
|
|
2022
Q4 | $15M | Buy |
1,635,385
+236,216
| +17% | +$2.17M | 0.15% | 152 |
|
|
2022
Q3 | $11.3M | Sell |
1,399,169
-547,043
| -28% | -$4.41M | 0.13% | 153 |
|
|
2022
Q2 | $15.5M | Buy |
1,946,212
+443,186
| +29% | +$3.52M | 0.17% | 134 |
|
|
2022
Q1 | $14.1M | Sell |
1,503,026
-126,953
| -8% | -$1.19M | 0.12% | 150 |
|
|
2021
Q4 | $12.9M | Buy |
1,629,979
+160,709
| +11% | +$1.27M | 0.11% | 163 |
|
|
2021
Q3 | $14.3M | Sell |
1,469,270
-98,055
| -6% | -$955K | 0.13% | 145 |
|
|
2021
Q2 | $15.7M | Sell |
1,567,325
-1,156,397
| -42% | -$11.6M | 0.14% | 135 |
|
|
2021
Q1 | $31.4M | Sell |
2,723,722
-352,855
| -11% | -$4.07M | 0.23% | 63 |
|
|
2020
Q4 | $39.1M | Buy |
+3,076,577
| New | +$39.1M | 0.26% | 47 |
|